Timeline: When Bad Research Changes Public Health Strategy
Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company ’s deception reverberated across... (Source: The Scientist)
Source: The Scientist - October 1, 2020 Category: Science Tags: Infographics Magazine Issue Source Type: news

Efficacy, safety of hydroxychloroquine vs placebo to prevent SARS-CoV-2 infection among health care
(JAMA Network) In this randomized clinical trial, daily hydroxychloroquine didn't prevent SARS-CoV-2 infection among hospital-based health care workers, although the trial was terminated early. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 30, 2020 Category: Infectious Diseases Source Type: news

Hydroxychloroquine no more effective than placebo in preventing COVID-19
(University of Pennsylvania School of Medicine) Clinical trial with COVID-19 testing of participants shows health care workers in contact with coronavirus patients who took hydroxychloroquine each day did not reduce their rate of infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 30, 2020 Category: Infectious Diseases Source Type: news

Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: Study
The study largely confirms results from a clinical trial in June that showed hydroxychloroquine was ineffective in preventing infection among people exposed to the new coronavirus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2020 Category: Pharmaceuticals Source Type: news

A New Look at Safety With Hydroxychloroquine in COVID-19 A New Look at Safety With Hydroxychloroquine in COVID-19
While a precipitous drop in use may make it almost moot, new data show only'modest'increases in QT prolongation and no arrhythmic deaths directly attributable to treatment.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 29, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Hydroxychloroquine Tied to Heart Problems Prior to Pandemic
MONDAY, Sept. 28, 2020 -- Real-world, pre-COVID-19 adverse events data show hydroxychloroquine (HCQ) and chloroquine (CQ) are associated with cardiovascular adverse events (CVAEs), according to a study published online Sept. 22 in the British... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 28, 2020 Category: Pharmaceuticals Source Type: news

Where Docs, Nurses Stand on COVID Emergency Use Authorizations Where Docs, Nurses Stand on COVID Emergency Use Authorizations
Medscape polled clinicians on their thoughts after questions were raised about evidence the FDA used to grant emergency authorizations for hydroxychloroquine, convalescent plasma, and remdesivir.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 25, 2020 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

Extracorporeal treatment for chloroquine, hydroxychloroquine, and quinine poisoning: systematic review and recommendations from the EXTRIP Workgroup - Berling I, King JD, Shepherd G, Hoffman RS, Alhatali B, Lavergne V, Roberts DM, Gosselin S, Wilson G, Nolin TD, Ghannoum M, EXTRIP workgroup.
BACKGROUND: Although chloroquine, hydroxychloroquine, and quinine are used for a range of medical conditions, recent research suggested a potential role in treating COVID-19. The resultant increase in prescribing was accompanied by an increase in adverse e... (Source: SafetyLit)
Source: SafetyLit - September 25, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of preCOVID19 reports
This analysis of the FAERS database found use of hydroxychloroquine and chloroquine was associated with a higher reporting rate of major CV adverse events, including cardiomyopathy (reporting OR 29.0), QT prolongation (4.5), cardiac arrhythmias (2.2) and heart failure (2.2). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 24, 2020 Category: Consumer Health News Source Type: news

Discontinuation of Hydroxychloroquine in Older SLE Patients Discontinuation of Hydroxychloroquine in Older SLE Patients
Hydroxychloroquine is an effective treatment for SLE, but long-term use may increase the risk for adverse events. At what point should discontinuation be considered?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 23, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Analysis reveals heart-related side effects of hydroxychloroquine and chloroquine
(Wiley) As the antimalarial drugs hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it's now more important than ever to have a thorough assessment of the safety of these medications. A recent analysis published in the British Journal of Clinical Pharmacology provides new insights. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 23, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19: Analysis reveals heart-related side effects of hydroxychloroquine, chloroquine
In the analysis of real-world data from the Food and Drug Administration Adverse Events Reporting System, a global database of post-marketing safety reports, hydroxychloroquine and chloroquine were associated with higher rates of various cardiovascular problems, including life-threatening heart rhythm events, heart failure, and damage to the heart muscle itself (termed cardiomyopathy). (Source: The Economic Times)
Source: The Economic Times - September 23, 2020 Category: Consumer Health News Source Type: news

The Lancet changes editorial policy after hydroxychloroquine Covid study retraction
New policy comes after serious quality control questions were raised about the data relied on by a study in the medical journalOne of the world ’s leading medical journals, the Lancet, has reformed its editorial policies following a shocking case of apparent research misconduct involving the study of hydroxychloroquine as a treatment for Covid-19.In May, the Lancet published a peer-reviewed study about the controversial drug hydroxychloroquine, which concluded Covid-19 patients who received the drug were dying at higher rates and experiencing more heart-related complications than other virus patients.Continue reading...
Source: Guardian Unlimited Science - September 22, 2020 Category: Science Authors: Melissa Davey Tags: Coronavirus outbreak Medical research Infectious diseases Microbiology Health Source Type: news

We Need a COVID-19 Vaccine. We Also Need Transparency About Its Development
The authorization of an effective vaccine will mark perhaps the biggest turning point in the battle against coronavirus, but only if enough people are willing to get vaccinated. There have been substantial declines in public willingness to get vaccinated against COVID-19, despite immense, unprecedented public investments in vaccine development. In one survey, barely half of Americans said they would get the vaccine as soon as it was available, numbers that will undermine the benefits of even a highly effective vaccine. It is no mystery why trust in a potential vaccine has plummeted. Operation Warp Speed, the Trump Administ...
Source: TIME: Health - September 18, 2020 Category: Consumer Health News Authors: Dr. Ashish K. Jha Tags: Uncategorized COVID-19 Source Type: news

How many more lives could be saved if Vitamin D had been distributed when the China virus hit?
(Natural News) The most important statistic concerning the covid-19 pandemic is the mortality rate. When covid-19 outbreaks were first announced, the mortality rate looked grim, as hospital systems relied on ventilators. As viable anti-viral treatments were suppressed (such as hydroxychloroquine), many hospital patients were literally left to die. Even worse: The local, state, and federal... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2020 Category: Consumer Health News Source Type: news

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology, PLOS Medicine
Review states large RCTs with appropriate monitoring are required to determine if chloroquine and hydroxychloroquine have preventive or treatment efficacy in COVID-19 and acceptable safety; and their use outside of clinical trials is not justified at this time. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 16, 2020 Category: Consumer Health News Source Type: news

CLAIM: Pharma giant Gilead sent death threats to French doctor for telling the world that hydroxychloroquine cures COVID-19
(Natural News) French scientist Dr. Didier Raoult, who successfully cured at least 80 Wuhan coronavirus (COVID-19) patients with hydroxychloroquine (HCQ), has come forward with claims that Gilead Sciences, Inc., a “deep state”-run biopharmaceutical company with ties to Donald Rumsfeld, recently sent him death threats for telling the world about this simple, inexpensive cure for the... (Source: NaturalNews.com)
Source: NaturalNews.com - September 15, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine and Chloroquine in COVID-19 Hydroxychloroquine and Chloroquine in COVID-19
How often are rheumatologists prescribing hydroxychloroquine and chloroquine for COVID-19 prophylaxis or treatment? A new survey provides insight.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Lawmakers Concerned About Political Meddling at CDC
In a September 14, 2020 letter to Health and Human Services (HHS) Secretary Alex Azar, House Energy and Commerce Committee Chairman Frank Pallone (D-NJ) and House Oversight and Investigations Subcommittee Chairwoman Diana DeGette (D-CO) expressed concerns about political interference at the Centers for Disease Control and Prevention (CDC) during the COVID-19 pandemic. The lawmakers have called for a briefing with Secretary Azar to address these concerns. The letter was in response to reports from Politico that the politically appointed HHS spokesperson, Michael Caputo, and his aides demanded and received the right to revi...
Source: Public Policy Reports - September 15, 2020 Category: Biology Authors: AIBS Source Type: news

JAMA article affirms benefits of hydroxychloroquine in treating COVID-19
(Natural News) The Journal of the American Medical Association (JAMA) has published a new research letter highlighting the proven benefits of hydroxychloroquine (HCQ) in successfully treating the Wuhan coronavirus (COVID-19). Entitled, “SARS-CoV-2 Infection Among Community Health Workers in India Before and After Use of Face Shields,” the paper explains that healthcare workers in India who... (Source: NaturalNews.com)
Source: NaturalNews.com - September 15, 2020 Category: Consumer Health News Source Type: news

Re-purposed hydroxychloroquine being used for mild, moderate COVID-19 cases: Harsh Vardhan
Re-purposed hydroxychloroquine is being used for mild but high risk and moderate COVID-19 cases, Union Health Minister Harsh Vardhan said in Rajya Sabha on Tuesday. (Source: The Economic Times)
Source: The Economic Times - September 15, 2020 Category: Consumer Health News Source Type: news

FDA hoarding 60 million doses of donated hydroxychloroquine that should be going to sick Americans
(Natural News) The American Association of Physicians and Surgeons (AAPS) is suing the U.S. Food and Drug Administration (FDA) for withholding from the public some 60 million doses of hydroxychloroquine (HCQ) that were donated by drug manufacturers to treat Wuhan coronavirus (COVID-19) patients. Currently, these 60 million doses of HCQ are under strict lock and... (Source: NaturalNews.com)
Source: NaturalNews.com - September 11, 2020 Category: Consumer Health News Source Type: news

Doctors' group: HCQ-hoarding FDA cares more about power than Americans' lives
(Natural News) The American Association of Physicians and Surgeons contends the Food and Drug Administration cares more about its power over drug stockpiles than the lives of Americans. (Article republished from WND.com) The AAPS has sued the FDA for withholding from its Strategic National Stockpile supplies of hydroxychloroquine, a drug that many studies show reduces... (Source: NaturalNews.com)
Source: NaturalNews.com - September 10, 2020 Category: Consumer Health News Source Type: news

The Case For Safer Emergency Use Authorizations
There needs to be effective treatments and vaccines available to stop the spread of this virus. The failures like hydroxychloroquine show that the EUA process must be robust enough that the authorized products do not harm the public or entrench public distrust of medicine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 9, 2020 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Increase Seen in Hydroxychloroquine Rx by Nonroutine Specialists
WEDNESDAY, Sept. 9, 2020 -- In March 2020, compared with March 2019, there was an 80-fold increase in new prescriptions for hydroxychloroquine by specialists who did not typically prescribe these medications, according to research published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2020 Category: Pharmaceuticals Source Type: news

Deprescribing Guidance for Hydroxychloroquine Drug Interactions Deprescribing Guidance for Hydroxychloroquine Drug Interactions
This study assessed the burden of potentially inappropriate medications that could be deprescribed if necessary to initiate treatment with hydroxychloroquine or other potential COVID-19 therapies.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 7, 2020 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Public health expert reveals the FDA and Fauci's shocking plot to bury hydroxychloroquine as potential COVID-19 cure
(Natural News) On the show “Life, Liberty & Levin,” host Mark Levin talked to Dr. Harvey A. Risch, a professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine, about hydroxychloroquine, a drug that can be used to prevent and treat coronavirus... (Source: NaturalNews.com)
Source: NaturalNews.com - September 7, 2020 Category: Consumer Health News Source Type: news

Study says cheap steroid reduces COVID-19 mortality by 33%
(Natural News) Some interesting news has emerged about a possible remedy for the Wuhan coronavirus (COVID-19) that, just like hydroxychloroquine (HCQ), is inexpensive and already widely available. A study published in the Journal of the American Medical Association found that the commonly used steroid drugs dexamethasone, hydrocortisone and methylprednisolone can help to reduce the mortality... (Source: NaturalNews.com)
Source: NaturalNews.com - September 6, 2020 Category: Consumer Health News Source Type: news

The war on Hydroxychloroquine can be traced back to Gilead, the drug maker looking to profit big from Remdesivir
(Natural News) It was beyond strange when the major media networks began to attack a pharmaceutical, especially in the middle of a pandemic. When did the major media networks ever criticize a drug? It turns out that controversial pharmaceutical is a cheap medicine that helps human cells uptake zinc so their immune system can recover... (Source: NaturalNews.com)
Source: NaturalNews.com - September 4, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020
This report describes prescribing patterns for hydroxychloroquine and chloroquine based on provider specialty following initial reports of treatment benefits for COVID-19. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 3, 2020 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report COVID-19 Coronavirus Disease 2019 Source Type: news

Public health researcher slams hydroxychloroquine naysayers – "The evidence is overwhelming”
(Natural News) As of August 31, there have been 849,383 global deaths due to coronavirus (COVID-19), with 183,579 deaths recorded in the U.S. Yet while a public health researcher from Yale has said that hydroxychloroquine (HCQ), a drug used to treat malaria, can also be used to fight coronavirus, those against the use of HCQ do so without any scientific... (Source: NaturalNews.com)
Source: NaturalNews.com - September 3, 2020 Category: Consumer Health News Source Type: news

More about chloroquine and hydroxychloroquine, CEBM (updated 30th August 2020)
VERDICT The hypothesis that the 4-aminoquinolines chloroquine and hydroxychloroquine may be beneficial in the treatment of COVID-19 is a weak one, based on poor mechanistic reasoning and inconsistent results of studies in vitro, in laboratory animals, and in humans. It is likely that even if chloroquine and hydroxychloroquine are effective in COVID-19, the beneficial effects will be small. The risks of adverse reactions to these drugs may be increased in patients who are acutely ill with severe COVID-19, in many of whom high doses are being used. Macrolide antibacterial drugs, such as azithromycin, clarithromycin, ery...
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Countries that used hydroxychloroquine to treat covid-19 saw a 73% lower fatality rate, meaning Fauci, the CDC and the FDA have conspired to KILL tens of thousands of Americans in order to protect the lucrative vaccine industry
(Natural News) An ongoing study that keeps track of how the nations of the world are faring with the Wuhan coronavirus (COVID-19) contains some eye-opening revelations about the effectiveness of hydroxychloroquine (HCQ). In all areas where HCQ is used – the United States is not one of them, thanks to Anthony Fauci and the left... (Source: NaturalNews.com)
Source: NaturalNews.com - September 2, 2020 Category: Consumer Health News Source Type: news

Doctors call out NEJM for publishing sloppy, fake science bashing hydroxychloroquine
(Natural News) World-renowned infectious disease specialist Dr. Didier Raoult, with the support of three of his colleagues, has published an “expression of concern” regarding some of the junk science that has been published in the New England Journal of Medicine (NEJM) as of late. Posted to the website of the University Hospital Institute IHU-Méditerranée Infection... (Source: NaturalNews.com)
Source: NaturalNews.com - August 31, 2020 Category: Consumer Health News Source Type: news

Improving FDA's COVID-19 vaccine authorization and approval process
On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19. On June 15, after a number of studies failed to find positive effects, the agency revoked this authorization. This chain of events raises questions about the speed, rigor and potential politicization of the authorization process. These actions also may have hurt the FDA's credibility and the public's trust in the agency, which could decrease the public's confidence in and adoption of eventual COVID-19 vaccines. (Source: World Pharma News)
Source: World Pharma News - August 31, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Improving FDA's COVID-19 vaccine authorization and approval process
(Dartmouth College) On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19, and on June 15, the agency revoked this authorization. In JAMA: The Journal of the American Medical Association, a research team proposes reforms that the FDA could implement to improve the EUA process and drug approvals during public health crises, which could increase the FDA's credibility and the public's trust in it. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 31, 2020 Category: Infectious Diseases Source Type: news

Senators call for probe after hydroxychloroquine was administered to patients in nursing homes
In a letter, US Senators Bob Casey (D-PA), Elizabeth Warren (D-MA) and Ron Wyden (D-OR) called for a federal investigation into hydroxychloroquine use at two nursing homes, (Source: the Mail online | Health)
Source: the Mail online | Health - August 28, 2020 Category: Consumer Health News Source Type: news

How a false hydroxychloroquine narrative was created
(Natural News) This unique and very revealing compilation of history and data by Dr. Meryl Nass, board certified in Internal Medicine, is essential reading. The medication concerned is without doubt a key to ending the terrible loss of life and devastating social and economic devastation caused by the unnecessary lockdowns and other harmful mitigation policies imposed by... (Source: NaturalNews.com)
Source: NaturalNews.com - August 27, 2020 Category: Consumer Health News Source Type: news

Trump-backed hydroxychloroquine doesn't treat Covid-19 and raises the risk of death
A review of 29 studies showed the controversial hydroxychloroquine does not save lives when given to Covid-19 patients. The drug has been touted by President Donald Trump as a 'game changer'. (Source: the Mail online | Health)
Source: the Mail online | Health - August 27, 2020 Category: Consumer Health News Source Type: news

Oleandrin: Trump allies pitch extract from poisonous plant to fight Covid
Experts raise concern over compound that has not been proven safe but could reach public as dietary supplementAllies of Donald Trump have promoted a plant extract called oleandrin to people seeking to ward off Covid-19. The plant the extract is derived from, oleander, is poisonous and there is no proof the compound is either safe or effective to treat or prevent Covid-19, experts say.But unlike other unproven and potentially dangerous Covid-19 “cures” pitched by Trump and his supporters, including the prescription antimalarial hydroxychloroquine, experts fear this compound could easily reach the public as a die...
Source: Guardian Unlimited Science - August 25, 2020 Category: Science Authors: Jessica Glenza Tags: US healthcare Coronavirus outbreak Donald Trump US politics Trump administration Science US news Pharmaceuticals industry Source Type: news

Hydroxychloroquine plus azithromycin increases heart risk, finds global study
(Columbia University Irving Medical Center) In the largest observational study of hydroxychloroquine and azithromycin, the drug combination has been linked to significant cardiovascular risks, including death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2020 Category: International Medicine & Public Health Source Type: news

Hydroxychloroquine reduces in-hospital COVID-19 mortality
(Istituto Neurologico Mediterraneo Neuromed I.R.C.C.S.) An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic. The research, conducted on 3,451 patients treated in 33 hospitals throughout the Italian territory, shows that the use of this drug reduces by 30% the risk of death in hospitalized patients affected by Covid-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2020 Category: International Medicine & Public Health Source Type: news

FDA Authorizes Use of Plasma From Recovered Patients to Treat COVID-19
(WASHINGTON) — President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,” one of his top health officials called “promising” and other health experts said needs more study before it’s celebrated. The announcement came after White House officials complained there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances. On the eve of the Republican National Convention, T...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Jonathan Lemire an Mike Stobbe / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Trump Suggests ‘Deep State’ At FDA Is Delaying Covid-19 Coronavirus Vaccine Testing
Trump also tweeted about the FDA's hydroxychloroquine decision. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 22, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick pharma Source Type: news

People everywhere are dying because the corrupt FDA won't let them have hydroxychloroquine
(Natural News) The Wuhan coronavirus (COVID-19) blame game rages on, with the Left accusing President Donald Trump of somehow not doing enough to address the crisis. But as anyone who has been paying attention well knows, Trump did try to help by promoting the use of hydroxychloroquine (HCQ), which the U.S. Food and Drug Administration... (Source: NaturalNews.com)
Source: NaturalNews.com - August 20, 2020 Category: Consumer Health News Source Type: news

Anti-malaria drug hydroxychloroquine does NOT prevent people from contracting coronavirus
A new study found about 34.6% of patients with lupus and/or rheumatoid arthritis taking the drug contracted coronavirus, just about as many as those with the conditions who didn't fall ill. (Source: the Mail online | Health)
Source: the Mail online | Health - August 19, 2020 Category: Consumer Health News Source Type: news

It's dangerous to ignore proof that hydroxychloroquine can save high-risk patients' lives, doctor warns
(Natural News) When we see figures like 165,000 Americans dying from COVID-19, the first question that comes to mind for a lot of people is, “Why can’t something be done about this? According to experts like Yale School of Public Health epidemiology professor Dr. Harvey Risch, the answer is that something can be done –... (Source: NaturalNews.com)
Source: NaturalNews.com - August 18, 2020 Category: Consumer Health News Source Type: news

Coronavirus Doctors Battle Another Scourge: Misinformation
Physicians say they regularly treat people more inclined to believe what they read on Facebook than what a medical professional tells them. (Source: NYT Health)
Source: NYT Health - August 17, 2020 Category: Consumer Health News Authors: Adam Satariano Tags: Coronavirus (2019-nCoV) Rumors and Misinformation Doctors Social Media Hydroxychloroquine (Drug) Emergency Medical Treatment Twitter American Journal of Tropical Medicine and Hygiene Source Type: news

After Hydroxychloroquine, Trump Is Now Seeking To Get Another Unproven Drug Approved By The FDA: Report
A senior Trump administration official said attempts to push the product, reportedly endorsed by Ben Carson and CEO of MyPillow, should give American “no comfort at night” in the midst of the pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 17, 2020 Category: Pharmaceuticals Authors: Isabel Togoh, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Leadership /leadership Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news

New study: Hydroxychloroquine ineffective as a preventive antiviral against COVID-19
(Case Western Reserve University) Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population. Their findings were recently published in the Annals of the Rheumatic Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 17, 2020 Category: Infectious Diseases Source Type: news